Torrent Pharma acquires 4 brands from Dr Reddy’s Laboratories
26 May 2022 | News
Torrent Pharma will take over the manufacturing, marketing and distribution of these brands in India
Image Credit: Shutterstock
Ahmedabad-based Torrent Pharmaceuticals has entered into an agreement with Dr Reddy's Laboratories to acquire four of its brands Styptovit-E, Finast, Finast-T and Dynapress.
Styptovit-E, a gynaecology product with estimated market size of ~Rs 500 crores (AIOCD data set), will further strengthen Torrent’s presence in the therapy. The acquisition of Finast; Finast-T, and Dynapress, which are used in the treatment of Benign Prostatic Hyperplasia (BPH), will aid in Torrent's presence in the Urology therapy.
As per the terms of the definitive agreement, Torrent Pharma will take over the manufacturing, marketing and distribution of these brands in India. The complete integration and transition of the brands are expected to be completed by June 2022.
